|
National Stock Number(NSN): 6505-01-121-2970 (6505011212970, 011212970)
| NIIN: |
01-121-2970 |
Item Name: |
FAT EMULSION INJECTION |
INC: |
35184
|
| FSC: |
6505
|
Assignment Date: |
Nov-04-1981 |
CRIT: |
X |
IIG: |
35184 |
| ISC: |
5 |
Date Standardized: |
Nov-04-1981 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9270 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
4326-01 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
LIPOSYN 10% |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NDC00074-4326-01 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DN |
S9M |
Y |
|
K |
U |
1 |
N |
$91.80 |
PG |
|
9L----- |
Nov-01-1990 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 1.20 PERCENTAGE, W/V EGG PHOSPHATIDES ACTIVE INGREDIENT |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
AQUEOUS |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE, INFUSION |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 MILLILITERS |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
WITH ADMINISTRATION SET |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,ABBOTT LABS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|